Thiotepa-based regimens are a valid alternative to total body irradiation-based reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia: a retrospective study on behalf of the Acute Leukemia Working Party of the EBMT.

Giorgia Battipaglia,Myriam Labopin,Stephan Mielke,Annalisa Ruggeri,Zubeyde Nur Ozkurt,Jean Henri Bourhis, Werner Rabitsch,Ibrahim Yakoub-Agha,Giovanni Grillo,Jaime Sanz,William Arcese,Yana Novis,Nathalie Fegueux,Alexandros Spyridonidis,Sebastian Giebel,Arnon Nagler,Fabio Ciceri,Mohamad Mohty

Transplantation and cellular therapy（2023）

引用 0|浏览27

暂无评分

摘要

In patients ≥40 years receiving a RIC regimen, use of a thiotepa-based regimen may represent a valid alternative to TBI-based regimens as no differences were observed in the main transplant outcomes.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要